Kyowa Kirin

Kyowa Kirin is a Japan-based global specialty pharmaceutical company that has established itself as a leader in drug discovery and biotechnology innovation for more than 70 years. The company is known for its commitment to developing innovative specialty medicines designed to address unmet medical needs in various therapeutic areas including oncology, immunology, and rare diseases. With a strong focus on R&D, Kyowa Kirin utilizes state-of-the-art technologies, including advanced antibody therapeutics and hematopoietic stem cell gene therapy, to create high-value pharmaceuticals.

The Kyowa Kirin Group prioritizes the health and well-being of individuals globally, striving to improve the quality of life for patients through novel treatments. This commitment is reflected in its extensive portfolio of drug candidates aimed at providing life-changing solutions for patients battling serious conditions. Kyowa Kirin emphasizes collaboration, integrity, and teamwork within its corporate culture, presenting a holistic approach to healthcare that bridges the gap between scientific innovation and patient care.